Quantum量子訊息有限公司
← 最新全球產業報告

DNA/RNA Sample Extraction and Isolation Market

研究執行與發布:TechSci Research · 發布日期 2026-05-01 · 177 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

出版商 TechSci Research產業別 Healthcare & Life Sciences出版日期 2026-05-01頁數 177報告編號 TSR-19443

授權報價

Single User License$4,500 USD
Multiple User License$5,500 USD
Custom Research License$8,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
DNA/RNA Sample Extraction and Isolation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Consumables, Instruments), By Technology (Silica-Based, Magnetic Particle Technology, Automated Spin Column-Based, Magnetic Bead-Based, Automated Liquid Handling Other Technologies), By Application (PCR, NGS, Cloning, Microarray, Blotting Techniques, Other Applications), By End User (Clinical Diagnostic and Forensic Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Others) By Region & Competition, 2021-2031F

報告摘要

Market Overview The Global DNA and RNA Sample Extraction and Isolation Market is projected to increase from USD 2.83 Billion in 2025 to USD 4.21 Billion by 2031, expanding at a CAGR of 6.84%. This sector focuses on purifying nucleic acids from biological samples to support precise genomic analysis and molecular testing. Primary growth drivers include the integration of precision medicine into clinical workflows, increased funding for life sciences research, and the rising incidence of infectious and genetic diseases. For instance, the American Cancer Society anticipates over two million new cancer cases in the United States in 2024, underscoring the critical need for robust diagnostic tools. However, market expansion is hindered by the high capital costs associated with automated extraction instruments. This financial barrier limits the adoption of automated solutions in smaller laboratories and developing regions where budgets are constrained. Consequently, these facilities often depend on labor-intensive manual methods, which can reduce overall efficiency and scalability in global genomic initiatives. Market Driver The increasing global prevalence of genetic disorders and infectious diseases serves as a primary growth accelerator for the market. As the burden of viral infections and chronic conditions rises, there is a parallel demand for accurate molecular diagnostics reliant on high-quality nucleic acid purification. The World Health Organization's 'Global Hepatitis Report 2024' estimated that in 2022, approximately 254 million people were living with hepatitis B and 50 million with hepatitis C. This widespread disease incidence necessitates the increased use of commercial extraction kits to handle high volumes of biological specimens for public health management. Simultaneously, substantial public and private funding for life sciences R&D provides the financial foundation for market accessibility and technological innovation. Investments allow industry leaders to create efficient platforms and enable laboratories to acquire them despite high costs. For example, Thermo Fisher Scientific invested $1.3 billion in R&D in 2023 to advance technology across its segments. Additionally, Danaher Corporation's subsidiary Cepheid reported roughly $650 million in respiratory testing revenue in the fourth quarter of 2023, highlighting the significant commercial value of molecular testing workflows dependent on effective sample preparation. Market Challenge A major barrier to the global market's expansion is the substantial capital investment required for automated extraction instruments. Smaller academic institutions and laboratories in developing regions often operate with limited budgets that cannot support the purchase of high-throughput purification platforms. This financial constraint forces reliance on manual extraction techniques, which are more time-consuming and variable than automated alternatives, thereby creating bottlenecks and limiting the throughput capacity for processing large sample volumes. This economic challenge is intensified by broader financial strains within the healthcare sector. In 2024, the American Hospital Association reported that hospital and health system expenses for supplies and equipment had risen by nearly 19 percent over the previous three years. These escalating operational costs reduce the funds available for acquiring new diagnostic technologies. Consequently, the adoption of efficient, automated DNA and RNA isolation systems is slowed, impeding the market's capacity to satisfy the growing demand for rapid genomic analysis. Market Trends The market is being reshaped by the development of specialized kits for cell-free DNA (cfDNA) and liquid biopsy as non-invasive diagnostic adoption grows. These applications demand highly efficient extraction technologies to isolate fragmented nucleic acids from blood with high purity, a critical requirement for oncology and reproductive health screening. Highlighting this demand, Natera reported processing approximately 735,800 tests in the first quarter of 2024, a 17.5% increase year-over-year, illustrating the massive scale of cfDNA isolation workflows. Concurrently, the rise of single-cell genomics is driving the need for sample preparation technologies that preserve RNA integrity at the individual cell level. With researchers focusing on cellular heterogeneity, there is increased demand for protocols that maximize yield from minute inputs while minimizing cell stress. This trend has spurred investment in platforms compatible with microfluidic analysis. For instance, 10x Genomics reported a 20% revenue increase to $618.7 million in 2023, reflecting the broader implementation of single-cell workflows and the associated reliance on specialized sample extraction. Key Market Players * Abnova Corporation. * Agilent Technologies, Inc. * Bio-Rad Laboratories, Inc. * Analytik Jena GmbH+Co. KG * F. Hoffmann-La Roche Ltd * Illumina, Inc. * MACHEREY-NAGEL GmbH & Co. KG * Merck KGaA * Norgen Biotek Corp. * Omega Bio-tek, Inc Report Scope In this report, the Global DNA and RNA Sample Extraction and Isolation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: # DNA and RNA Sample Extraction and Isolation Market, By Product Type * Consumables * Instruments # DNA and RNA Sample Extraction and Isolation Market, By Technology * Silica-Based * Magnetic Particle Technology * Automated Spin Column-Based * Magnetic Bead-Based * Automated Liquid Handling Other Technologies # DNA and RNA Sample Extraction and Isolation Market, By Application * PCR * NGS * Cloning * Microarray * Blotting Techniques * Other Applications # DNA and RNA Sample Extraction and Isolation Market, By End User * Clinical Diagnostic and Forensic Laboratories * Pharmaceutical and Biotechnology Companies * Contract Research Organizations * Others # DNA and RNA Sample Extraction and Isolation Market, By Region * North America United States Canada Mexico * Europe France United Kingdom Italy Germany Spain * Asia Pacific China India Japan Australia South Korea * South America Brazil Argentina Colombia * Middle East & Africa South Africa Saudi Arabia UAE Competitive Landscape Company Profiles: Detailed analysis of the major companies present in the Global DNA and RNA Sample Extraction and Isolation Market. Available Customizations: Global DNA and RNA Sample Extraction and Isolation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: Company Information * Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview 1.1. Market Definition 1.2. Scope of the Market 1.2.1. Markets Covered 1.2.2. Years Considered for Study 1.2.3. Key Market Segmentations 2. Research Methodology 2.1. Objective of the Study 2.2. Baseline Methodology 2.3. Key Industry Partners 2.4. Major Association and Secondary Sources 2.5. Forecasting Methodology 2.6. Data Triangulation & Validation 2.7. Assumptions and Limitations 3. Executive Summary 3.1. Overview of the Market 3.2. Overview of Key Market Segmentations 3.3. Overview of Key Market Players 3.4. Overview of Key Regions/Countries 3.5. Overview of Market Drivers, Challenges, Trends 4. Voice of Customer 5. Global DNA and RNA Sample Extraction and Isolation Market Outlook 5.1. Market Size & Forecast 5.1.1. By Value 5.2. Market Share & Forecast 5.2.1. By Product Type (Consumables, Instruments) 5.2.2. By Technology (Silica-Based, Magnetic Particle Technology, Automated Spin Column-Based, Magnetic Bead-Based, Automated Liquid Handling Other Technologies) 5.2.3. By Application (PCR, NGS, Cloning, Microarray, Blotting Techniques, Other Applications) 5.2.4. By End User (Clinical Diagnostic and Forensic Laboratories, Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Others) 5.2.5. By Region 5.2.6. By Company (2025) 5.3. Market Map 6. North America DNA and RNA Sample Extraction and Isolation Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Product Type 6.2.2. By Technology 6.2.3. By Application 6.2.4. By End User 6.2.5. By Country 6.3. North America: Country Analysis 6.3.1. United States DNA and RNA Sample Extraction and Isolation Market Outlook 6.3.1.1. Market Size & Forecast 6.3.1.1.1. By Value 6.3.1.2. Market Share & Forecast 6.3.1.2.1. By Product Type 6.3.1.2.2. By Technology 6.3.1.2.3. By Application 6.3.1.2.4. By End User 6.3.2. Canada DNA and RNA Sample Extraction and Isolation Market Outlook 6.3.2.1. Market Size & Forecast 6.3.2.1.1. By Value 6.3.2.2. Market Share & Forecast 6.3.2.2.1. By Product Type 6.3.2.2.2. By Technology 6.3.2.2.3. By Application 6.3.2.2.4. By End User 6.3.3. Mexico DNA and RNA Sample Extraction and Isolation Market Outlook 6.3.3.1. Market Size & Forecast 6.3.3.1.1. By Value 6.3.3.2. Market Share & Forecast 6.3.3.2.1. By Product Type 6.3.3.2.2. By Technology 6.3.3.2.3. By Application 6.3.3.2.4. By End User 7. Europe DNA and RNA Sample Extraction and Isolation Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Product Type 7.2.2. By Technology 7.2.3. By Application 7.2.4. By End User 7.2.5. By Country 7.3. Europe: Country Analysis 7.3.1. Germany DNA and RNA Sample Extraction and Isolation Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Product Type 7.3.1.2.2. By Technology 7.3.1.2.3. By Application 7.3.1.2.4. By End User 7.3.2. France DNA and RNA Sample Extraction and Isolation Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Product Type 7.3.2.2.2. By Technology 7.3.2.2.3. By Application 7.3.2.2.4. By End User 7.3.3. United Kingdom DNA and RNA Sample Extraction and Isolation Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecast 7.3.3.2.1. By Product Type 7.3.3.2.2. By Technology 7.3.3.2.3. By Application 7.3.3.2.4. By End User 7.3.4. Italy DNA and RNA Sample Extraction and Isolation Market Outlook 7.3.4.1. Market Size & Forecast 7.3.4.1.1. By Value 7.3.4.2. Market Share & Forecast 7.3.4.2.1. By Product Type 7.3.4.2.2. By Technology 7.3.4.2.3. By Application 7.3.4.2.4. By End User 7.3.5. Spain DNA and RNA Sample Extraction and Isolation Market Outlook 7.3.5.1. Market Size & Forecast 7.3.5.1.1. By Value 7.3.5.2. Market Share & Forecast 7.3.5.2.1. By Product Type 7.3.5.2.2. By Technology 7.3.5.2.3. By Application 7.3.5.2.4. By End User 8. Asia Pacific DNA and RNA Sample Extraction and Isolation Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Product Type 8.2.2. By Technology 8.2.3. By Application 8.2.4. By End User 8.2.5. By Country 8.3. Asia Pacific: Country Analysis 8.3.1. China DNA and RNA Sample Extraction and Isolation Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Product Type 8.3.1.2.2. By Technology 8.3.1.2.3. By Application 8.3.1.2.4. By End User 8.3.2. India DNA and RNA Sample Extraction and Isolation Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Product Type 8.3.2.2.2. By Technology 8.3.2.2.3. By Application 8.3.2.2.4. By End User 8.3.3. Japan DNA and RNA Sample Extraction and Isolation Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Product Type 8.3.3.2.2. By Technology 8.3.3.2.3. By Application 8.3.3.2.4. By End User 8.3.4. South Korea DNA and RNA Sample Extraction and Isolation Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Product Type 8.3.4.2.2. By Technology 8.3.4.2.3. By Application 8.3.4.2.4. By End User 8.3.5. Australia DNA and RNA Sample Extraction and Isolation Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Product Type 8.3.5.2.2. By Technology 8.3.5.2.3. By Application 8.3.5.2.4. By End User 9. Middle East & Africa DNA and RNA Sample Extraction and Isolation Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Product Type 9.2.2. By Technology 9.2.3. By Application 9.2.4. By End User 9.2.5. By Country 9.3. Middle East & Africa: Country Analysis 9.3.1. Saudi Arabia DNA and RNA Sample Extraction and Isolation Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Product Type 9.3.1.2.2. By Technology 9.3.1.2.3. By Application 9.3.1.2.4. By End User 9.3.2. UAE DNA and RNA Sample Extraction and Isolation Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Product Type 9.3.2.2.2. By Technology 9.3.2.2.3. By Application 9.3.2.2.4. By End User 9.3.3. South Africa DNA and RNA Sample Extraction and Isolation Market Outlook 9.3.3.1. Market Size & Forecast 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Product Type 9.3.3.2.2. By Technology 9.3.3.2.3. By Application 9.3.3.2.4. By End User 10. South America DNA and RNA Sample Extraction and Isolation Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Product Type 10.2.2. By Technology 10.2.3. By Application 10.2.4. By End User 10.2.5. By Country 10.3. South America: Country Analysis 10.3.1. Brazil DNA and RNA Sample Extraction and Isolation Market Outlook 10.3.1.1. Market Size & Forecast 10.3.1.1.1. By Value 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Product Type 10.3.1.2.2. By Technology 10.3.1.2.3. By Application 10.3.1.2.4. By End User 10.3.2. Colombia DNA and RNA Sample Extraction and Isolation Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1. By Value 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Product Type 10.3.2.2.2. By Technology 10.3.2.2.3. By Application 10.3.2.2.4. By End User 10.3.3. Argentina DNA and RNA Sample Extraction and Isolation Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1. By Value 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Product Type 10.3.3.2.2. By Technology 10.3.3.2.3. By Application 10.3.3.2.4. By End User 11. Market Dynamics 11.1. Drivers 11.2. Challenges 12. Market Trends & Developments 12.1. Merger & Acquisition (If Any) 12.2. Product Launches (If Any) 12.3. Recent Developments 13. Global DNA and RNA Sample Extraction and Isolation Market: SWOT Analysis 14. Porter's Five Forces Analysis 14.1. Competition in the Industry 14.2. Potential of New Entrants 14.3. Power of Suppliers 14.4. Power of Customers 14.5. Threat of Substitute Products 15. Competitive Landscape 15.1. Abnova Corporation. 15.1.1. Business Overview 15.1.2. Products & Services 15.1.3. Recent Developments 15.1.4. Key Personnel 15.1.5. SWOT Analysis 15.2. Agilent Technologies, Inc. 15.3. Bio-Rad Laboratories, Inc. 15.4. Analytik Jena GmbH+Co. KG 15.5. F. Hoffmann-La Roche Ltd 15.6. Illumina, Inc. 15.7. MACHEREY-NAGEL GmbH & Co. KG 15.8. Merck KGaA 15.9. Norgen Biotek Corp. 15.10. Omega Bio-tek, Inc 16. Strategic Recommendations 17. About Us & Disclaimer

提及公司

1 Abnova Corporation.2 Agilent Technologies, Inc.3 Bio-Rad Laboratories, Inc.4 Analytik Jena GmbH+Co. KG5 F. Hoffmann-La Roche Ltd6 Illumina, Inc.7 MACHEREY-NAGEL GmbH & Co. KG8 Merck KGaA9 Norgen Biotek Corp.10 Omega Bio-tek, Inc

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 TechSci Research 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們